Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosentan in poorly controlled asthma
NCT00815347Phase 2Terminated
- Sponsor
- UConn Health
- Start
- Dec 2008
- Primary completion
- Sep 2010
- Modality
- Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of bosentan in asthma, sponsored by UConn Health. Started Dec 2008; status: terminated.
02
Drugs
bosentan
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00815347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00815347.